载脂蛋白E
感觉
队列
生物标志物
医学
内科学
认知功能衰退
认知
单变量分析
淀粉样蛋白(真菌学)
淀粉样变性
心理学
痴呆
临床心理学
疾病
精神科
病理
多元分析
生物
社会心理学
生物化学
作者
Olin Janssen,Willemijn J. Jansen,Stephanie J. B. Vos,Merçé Boada,Lucilla Parnetti,Tomasz Gabryelewicz,Tormod Fladby,José Luís Molinuevo,Sylvia Villeneuve,Jakub Hort,Stéphane Epelbaum,Alberto Lleó,Sebastiaan Engelborghs,Wiesje M. van der Flier,Susan Landau,Julius Popp,Anders Wallin,Philip Scheltens,Marcel G. M. Olde Rikkert,Peter J. Snyder
摘要
Abstract Introduction The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD‐specific characteristics (informant confirmation, domain‐specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene ( APOE ) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Results Between cohorts, amyloid positivity in 70‐year‐olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant‐confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Discussion Next to age, setting, and APOE ε4 carriership, SCD‐specific characteristics may facilitate the identification of amyloid‐positive individuals.
科研通智能强力驱动
Strongly Powered by AbleSci AI